國家級人體生物資料庫整合平台共同資料模式實作指引(NBCT Common Data Model IG)
0.1.0 - trial-use

Publication Build: This will be filled in by the publication tooling

## ValueSet: 申報醫院化學治療值集

Official URL: https://www.ghd.tw/cdm-fhir/fhir/ValueSet/CRLF-Chem-DH | Version: 0.1.0
Active as of 2024-09-01 | Computable Name: CRLFChemDHValueSet

CRLF申報醫院化學治療值集

References

- Procedure CRLF-申報醫院化學治療

### Logical Definition (CLD)

Generated Narrative: ValueSet CRLF-Chem-DH

- Include all codes defined in `https://www.ghd.tw/cdm-fhir/fhir/CodeSystem/CRLF-Chem-DH`

### Expansion

Generated Narrative: ValueSet

Expansion based on codesystem 申報醫院化學治療代碼系統 v0.1.0 (CodeSystem)

This value set contains 25 concepts

Code | System | Display
00 | https://www.ghd.tw/cdm-fhir/fhir/CodeSystem/CRLF-Chem-DH | (1)未接受化學治療，化學治療非首次療程的一部份 (2)由屍體解剖時才診斷為癌症
01 | https://www.ghd.tw/cdm-fhir/fhir/CodeSystem/CRLF-Chem-DH | 接受全身性化學治療
02 | https://www.ghd.tw/cdm-fhir/fhir/CodeSystem/CRLF-Chem-DH | 接受全身性化學治療，且只有一種化學藥物。(僅適用於 2017(含)診斷年之前的個案)
03 | https://www.ghd.tw/cdm-fhir/fhir/CodeSystem/CRLF-Chem-DH | 接受全身性化學治療，且超過一種以上的化學藥物。(僅適用於 2017(含)診斷年之前 的個案)
04 | https://www.ghd.tw/cdm-fhir/fhir/CodeSystem/CRLF-Chem-DH | 個案原發部位僅接受局部動脈栓塞化學治療(TACE)
05 | https://www.ghd.tw/cdm-fhir/fhir/CodeSystem/CRLF-Chem-DH | 個案原發部位接受局部動脈栓塞化學 (TACE)及全身性化學治療
06 | https://www.ghd.tw/cdm-fhir/fhir/CodeSystem/CRLF-Chem-DH | 個案原發部位接受局部動脈栓塞化學 (TACE)及其他局部性化學治療
07 | https://www.ghd.tw/cdm-fhir/fhir/CodeSystem/CRLF-Chem-DH | 個案原發部位接受局部動脈栓塞化學 (TACE)、其他局部性及全身性化學治療
08 | https://www.ghd.tw/cdm-fhir/fhir/CodeSystem/CRLF-Chem-DH | 個案僅接受局部性化學治療(不包含TACE) (1)肋膜腔注射 (2)心包膜腔注射 (3)腹腔內注射 (4)膀胱灌注 (5)脊髓腔內注射(intrathecal) (6)其他局部化學治療(例如：BCNU wafer implantation)
09 | https://www.ghd.tw/cdm-fhir/fhir/CodeSystem/CRLF-Chem-DH | 個案同時接受全身性及局部性化學治療(不包含TACE)
10 | https://www.ghd.tw/cdm-fhir/fhir/CodeSystem/CRLF-Chem-DH | 肝轉移個案接受局部動脈栓塞化學治療(TACE)
11 | https://www.ghd.tw/cdm-fhir/fhir/CodeSystem/CRLF-Chem-DH | 肝轉移個案接受局部動脈栓塞化學(TACE)及全身性化學治療
12 | https://www.ghd.tw/cdm-fhir/fhir/CodeSystem/CRLF-Chem-DH | 肝轉移個案接受局部動脈栓塞化學治療(TACE)及其他局部性化學治療
13 | https://www.ghd.tw/cdm-fhir/fhir/CodeSystem/CRLF-Chem-DH | 肝轉移個案接受局部動脈栓塞化學治療(TACE)、其他局部性及全身性化學治療
20 | https://www.ghd.tw/cdm-fhir/fhir/CodeSystem/CRLF-Chem-DH | 僅接受臨床試驗化學治療
21 | https://www.ghd.tw/cdm-fhir/fhir/CodeSystem/CRLF-Chem-DH | 同時接受化學治療(全身性或/與局部性)及臨床試驗化學治療
30 | https://www.ghd.tw/cdm-fhir/fhir/CodeSystem/CRLF-Chem-DH | 僅接受雙盲試驗化學治療
31 | https://www.ghd.tw/cdm-fhir/fhir/CodeSystem/CRLF-Chem-DH | 同時接受化學治療(全身性或/與局部性)及雙盲試驗化學治療
82 | https://www.ghd.tw/cdm-fhir/fhir/CodeSystem/CRLF-Chem-DH | 化學治療因禁忌症或個案其他危險因素(併發症、年邁)而未建議或給予
83 | https://www.ghd.tw/cdm-fhir/fhir/CodeSystem/CRLF-Chem-DH | 化學治療因疾病進展而未建議或給予
85 | https://www.ghd.tw/cdm-fhir/fhir/CodeSystem/CRLF-Chem-DH | 化學治療是既定之首次療程計畫中的一部分，但因個案未接受治療前即死亡或病危出院
86 | https://www.ghd.tw/cdm-fhir/fhir/CodeSystem/CRLF-Chem-DH | 化學治療雖然是既定之首次療程計畫中的一部分，未執行且病歷並未記載未執行的原因；或於他院執行化學治療
87 | https://www.ghd.tw/cdm-fhir/fhir/CodeSystem/CRLF-Chem-DH | 化學治療雖然是既定之首次療程計畫中的一部分，但未執行，且病歷記載個案或其家屬拒絕此項治療
88 | https://www.ghd.tw/cdm-fhir/fhir/CodeSystem/CRLF-Chem-DH | 化學治療雖是既定之首次療程計畫中的一部分，但摘錄時尚未執行
99 | https://www.ghd.tw/cdm-fhir/fhir/CodeSystem/CRLF-Chem-DH | (1)由於病歷未記載，所以不知道化學治療是否有被建議或是已經執行 (2)僅由死亡證明書得知個案有癌症

Explanation of the columns that may appear on this page:

Level | A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies
System | The source of the definition of the code (when the value set draws in codes defined elsewhere)
Code | The code (used as the code in the resource instance)
Display | The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application
Definition | An explanation of the meaning of the concept
Comments | Additional notes about how to use the code